Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02710422 · ClinicalTrials.gov registry record · Phase 2
Miami Membrane for Potency (MMEP) Trial
A Phase 2 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT02710422 is a Phase 2 study that was terminated before completion, run by University of Miami. The registered enrollment target is 24 participants.
The verdict
NCT02710422, a Phase 2 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The use of dehydrated human amnionic membrane allograft improves erectile function recovery (as measured by (Sexual History Inventory for Men (SHIM) score) at 12 months after robotic assisted radical prostatectomy (RARP) compared to a control group with no allograft.
Interventions
- BIOLOGICAL Amniotic Membrane Placement
- BEHAVIORAL EPIC 26
- OTHER PSA Measurement
- BEHAVIORAL Sexual History Inventory for Men
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-05-17 |
| Est. Completion | 2019-01-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02710422
The ClinicalTrials.gov registry entry for NCT02710422 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Amniotic Membrane Placement is the first listed.
NCT02710422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02710422 about?
NCT02710422 is a clinical study titled "Miami Membrane for Potency (MMEP) Trial". The use of dehydrated human amnionic membrane allograft improves erectile function recovery (as measured by (Sexual History Inventory for Men (SHIM) score) at 12 months after robotic assisted radical prostatectomy (RARP) compared to a control group with no allograft.
What is the current status of trial NCT02710422?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2016-05-17. Estimated completion is 2019-01-22.
What interventions are being tested in trial NCT02710422?
The interventions under investigation include: Amniotic Membrane Placement (BIOLOGICAL), EPIC 26 (BEHAVIORAL), PSA Measurement (OTHER), Sexual History Inventory for Men (BEHAVIORAL).
Who is sponsoring clinical trial NCT02710422?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.